Charles Eden

Stock Analyst at UBS

(2.74)
# 2,873
Out of 5,125 analysts
281
Total ratings
51.2%
Success rate
1.3%
Average return

Stocks Rated by Charles Eden

Symrise AG
Jun 18, 2026
Reiterated: Buy
Price Target: €94.00
Current: €93.96
Upside: +0.04%
Givaudan SA
Jun 12, 2026
Reiterated: Hold
Price Target: CHF 3,100 → CHF 3,270
Current: CHF 4,048
Upside: -19.22%
Softcare Limited
May 27, 2026
Reiterated: Buy
Price Target: $42.20
Current: $28.52
Upside: +47.97%
DSM-Firmenich AG
May 8, 2026
Reiterated: Buy
Price Target: €85.00 → €86.00
Current: €105.70
Upside: -18.64%
Wacker Chemie AG
Apr 29, 2026
Reiterated: Buy
Price Target: €84.00
Current: €80.30
Upside: +4.61%
Air Liquide S.A.
Apr 28, 2026
Reiterated: Buy
Price Target: €190.89
Current: €190.34
Upside: +0.29%
Croda International Plc
Apr 23, 2026
Reiterated: Buy
Price Target: 4,300p
Current: 3,641p
Upside: +18.10%
Essity AB (publ)
Apr 10, 2026
Reiterated: Buy
Price Target: kr 310.00 → kr 290.00
Current: kr 291.50
Upside: -0.51%
Novozymes A/S
Feb 14, 2024
Reiterated: Hold
Price Target: $58
Current: $66.25
Upside: n/a
Elementis plc
Sep 21, 2023
Reiterated: Buy
Price Target: 140p
Current: 190p
Upside: n/a
Reiterated: Sell
Price Target: €89.00 → €85.00
Current: €85.34
Upside: n/a
Downgraded: Sell
Price Target: €71.00 → €58.00
Current: €68.32
Upside: n/a
Reiterated: Buy
Price Target: €252.00 → €310.00
Current: €443.85
Upside: n/a
Reiterated: Sell
Price Target: €62.00
Current: €87.36
Upside: n/a
Reiterated: Buy
Price Target: CHF 117.00 → CHF 105.00
Current: CHF 86.41
Upside: n/a
Reiterated: Hold
Price Target: 6,500p → 5,700p
Current: 5,656p
Upside: n/a
Reiterated: Hold
Price Target: 4,850p → 4,150p
Current: 4,939p
Upside: n/a
Initiated Coverage: Buy
Price Target: n/a
Current: $290.50
Upside: n/a
Upgraded: Hold
Price Target: n/a
Current: $0.135
Upside: n/a
Initiated Coverage: Hold
Price Target: $51
Current: $111.76
Upside: n/a
Initiated Coverage: Sell
Price Target: $124
Current: $110.76
Upside: n/a
Upgraded: Buy
Price Target: n/a
Current: $106.60
Upside: n/a
Initiated Coverage: Buy
Price Target: $102
Current: $113.43
Upside: n/a